Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Medtecs International Corporation Ltd. ( (SG:546) ) has issued an update.
Medtecs International Corporation Limited has provided a monthly update on the liquidation of its subsidiary Resilient Medical, informing shareholders that the liquidator filed the relevant application with the High Court of Singapore on 22 January 2026, with a hearing scheduled for 3 February 2026 to address the dissolution of Resilient Medical. The board stated that, based on current information, the winding-up of Resilient Medical and the transfer of the entire issued share capital of RMKH SG to Medtecs via a dividend in specie are not expected to have a material impact on the group’s net tangible assets per share or earnings per share for the financial year ending 31 December 2026, though the company will continue to issue further updates on any significant developments and has urged investors to exercise caution when trading its shares.
More about Medtecs International Corporation Ltd.
Medtecs International Corporation Limited is a Bermuda-incorporated company whose group operates in the medical and healthcare sector. Through its subsidiaries, it is involved in providing medical-related products and services, with its corporate developments and restructuring activities closely watched by shareholders and market participants on the Singapore Exchange’s Catalist board.
Average Trading Volume: 1,326,539
Technical Sentiment Signal: Sell
Current Market Cap: S$70.49M
For detailed information about 546 stock, go to TipRanks’ Stock Analysis page.